Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes

Journal of Dermatological Science

Volumn 64, Issue 2, 2011, Pages 108-118

  Hoq, Md Imranul ^a,b   Niyonsaba, François ^a   Ushio, Hiroko ^a   Aung, Gyi ^a,c   Okumura, Ko ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CHITTAGONG   (Bangladesh)

^c Yangon General Hospital   (Myanmar)

Author keywords

Antimicrobial peptide; Catestatin; Keratinocyte; Migration; Neuroendocrine; Proliferation

Indexed keywords

ARGININE; BROXURIDINE; CALCIUM; CATESTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTAMINE; GLYCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROLINE; PROTEIN KINASE B; SERINE; SYNAPTOPHYSIN;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

AMINO ACID SEQUENCE; CALCIUM; CELL MOVEMENT; CELL PROLIFERATION; CHROMOGRANIN A; GTP-BINDING PROTEINS; HUMANS; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYPE C PHOSPHOLIPASES;

EID: 80053384405     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.08.001     Document Type: Article

References (41)

1. Schauber J., Gallo R.L. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008, 122:261-266.
2. Braff M.H., Bardan A., Nizet V., Gallo R.L. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005, 125:9-13.
3. Niyonsaba F., Nagaoka I., Ogawa H., Okumura K. Multifunctional antimicrobial proteins and peptides: natural activators of immune systems. Curr Pharm Des 2009, 15:2393-2413.
4. Shooshtarizadeh P., Zhang D., Chich J.F., Gasnier C., Schneider F., Haikel Y., et al. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept 2010, 165:102-110.
5. Radek K.A., Lopez-Garcia B., Hupe M., Niesman I.R., Elias P.M., Taupenot L., et al. The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol 2008, 128:1525-1534.
6. Briolat J., Wu S.D., Mahata S.K., Gothier B., Bagnard D., Chasserot-Golaz S., et al. New antimicrobial activity for the catecholamine release inhibitory peptide from chromogranin A. Cell Mol Life Sci 2005, 62:377-385.
7. Mahata S.K., OóConnor D.T., Mahata M., Yoo S.H., Taupenot L., Wu H., et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 1997, 100:1623-1633.
8. Wen G., Mahata S.K., Cadman P., Mahata M., Ghosh S., Mahapatra N.R., et al. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet 2004, 74:197-207.
9. Mahata S.K., Mahata M., Wen G., Wong W.B., Mahapatra N.R., Hamilton B.A., et al. The catecholamine release-inhibitory "catestatin" fragment of chromogranin A: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol 2004, 66:1180-1191.
10. Egger M., Beer A.G., Theurl M., Schgoer W., Hotter B., Tatarczyk T., et al. Monocyte migration: a novel effect and signaling pathways of catestatin. Euro J Pharmacol 2008, 598:104-111.
11. Theurl M., Schgoer W., Albrecht K., Jeschke J., Egger M., Beer A.G.E., et al. The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res 2010, 107:1326-1335.
12. Aung G., Niyonsaba F., Ushio H., Kajiwara N., Saito H., Ikeda S., et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology 2011, 132:527-539.
13. Aung G., Niyonsaba F., Ushio H., Hoq M.I., Ikeda S., Ogawa H., et al. A neuroendocrine antimicrobial peptide, catestatin, stimulates interleukin-8 production from human keratinocytes via activation of mitogen-activated protein kinases. J Dermatol Sci 2011, 61:142-144.
14. Zahm J.M., Debordeaux C., Raby B., Klossek J.M., Bonnet N., Puchelle E. Mitogenic effect of recombinant HGF on airway epithelial cells during the in vitro wound repair of the respiratory epithelium. J Cell Physiol 2000, 185:447-453.
15. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007, 127:594-604.
16. Li Y., Fan J., Chen N., Li W., Woodley D.T. Transforming growth factor-α: a major human serum factor that promotes human keratinocyte migration. J Invest Dermatol 2006, 126:2096-2105.
17. Tu C.L., Oda Y., Komuves L., Bikle D.D. The role of the calcium-sensing receptor in epidermal differentiation. Cell Calcium 2004, 35:265-273.
18. Chen X., Niyonsaba F., Ushio H., Hara M., Yokoi H., Matsumoto K., et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007, 127:594-604.
19. Tokumaru S., Sayama K., Shirakata Y., Komatsuzawa H., Ouhara K., Hanakawa Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 2005, 175:4662-4668.
20. Bito T., Sumita N., Ashida M., Budiyanto A., Ueda M., Ichihashi M., et al. Inhibition of epidermal growth factor receptor and PI3K/Akt signaling suppresses cell proliferation and survival through regulation of stat3 activation in human cutaneous squamous cell carcinoma. J Skin Cancer 2011, 874571:2011.
21. McCawley L.J., Li S., Wattenberg E.V., Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem 1999, 274:4347-4353.
22. Biswas N., Vaingankar S.M., Mahata M., Das M., Gayen J.R., Taupenot L., et al. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology 2008, 149:749-757.
23. 2+ signaling in alveolar epithelial cells through gap junctions and by extracellular ATP. Am J Physiol Lung Cell Mol Physiol 2001, 280:L221-L228.
24. Isakson B.E., Seedorf G.J., Lubman R.L., Evans W.H., Boitano S. Cell-cell communication in heterocellular cultures of alveolar epithelial cells. Am J Respir Cell Mol Biol 2003, 29:552-561.
25. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 2000, 80:1291-1335.
26. Bhattacharya R., Kwon J., Li X., Wang E., Patra S., Bida J.P., et al. Distinct role of PLCβ3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci 2009, 122:1025-1034.
27. Bertagnolo V., Benedusi M., Brugnoli F., Lanuti P., Marchisio M., Querzoli P., et al. Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells. Carcinogenesis 2007, 28:1638-1645.
28. Andl C.D., Mizushima T., Oyama K., Bowser M., Nakagawa H., Rustgi A.K. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 2004, 287:G1227-G1237.
29. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 1999, 18:4657-4668.
30. Vanhaesebroeck B., Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000, 346:561-576.
31. Pankow S., Bamberger C., Klippel A., Werner S. Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase. J Cell Sci 2006, 119:4033-4046.
32. Wu T.T., Hsieh Y.H., Hsieh Y.S., Liu J.Y. Reduction of PKCα decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 2008, 103:9-20.
33. Dunzendorfer S., Schratzberger P., Reinisch N., Kahler C.M., Wiedermann C.J. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood 1998, 91:1527-1532.
34. Turner S.J., Domin J., Waterfield M.D., Ward S.G., Westwick J. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2α. J Biol Chem 1998, 273:25987-32595.
35. Henry M.K., Nimbalkar D., Hohl R.J., Quelle F.W. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoetic cells. Exp Cell Res 2004, 299:257-266.
36. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., et al. Central role for G-protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000, 287:1049-1053.
37. Jones G.E., Prigmore E., Calvez R., Hogan C., Dunn G.A., Hirsch E., et al. Requirement for PI3-kinase gamma in macrophage migration to MCP-1 and CSF-1. Exp Cell Res 2003, 290:120-131.
38. Madeddu P., Kraenkel N., Barcelos L.S., Siragusa M., Campagnolo P., Oikawa A., et al. Phosphoinositide 3-kinase γ gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler Thromb Vasc Biol 2008, 28:68-76.
39. Heidenreich R., Röcken M., Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 2009, 90:232-248.
40. Rennekampff H.O., Hansbrough J.F., Kiessig V., Doré C., Sticherling M., Schröder J.M. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000, 93:41-54.
41. O'Connor D.T., Kailasam M.T., Kennedy B.P., Ziegler M.G., Yanaihara N., Parmer R.J. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 2002, 20:1335-1345.